ORGS - Orgenesis Inc
IEX Last Trade
0.6723
-0.016 -2.306%
Share volume: 84,483
Last Updated: Fri 30 Aug 2024 08:38:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.69
-0.02
-2.25%
Fundamental analysis
33%
Profitability
25%
Dept financing
15%
Liquidity
60%
Performance
39%
Performance
5 Days
-8.61%
1 Month
4.35%
3 Months
37.84%
6 Months
7.53%
1 Year
18.04%
2 Year
-64.37%
Key data
Stock price
$0.67
DAY RANGE
N/A - N/A
52 WEEK RANGE
$0.25 - $1.08
52 WEEK CHANGE
$0.16
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/13/2024
Company detail
CEO: Vered Caplan
Region: US
Website: https://www.orgenesis.com/
Employees: 72
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: https://www.orgenesis.com/
Employees: 72
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
orgenesis inc (orgs) is a medical device company located in 21 sparrow cir, white plains, new york, united states.
Recent news